PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Milner Therapeutics Institute, University of Cambridge, Cambridge, UK.\', \'Milner Therapeutics Institute, University of Cambridge, Cambridge, UK; Department of Surgery, University of Cambridge, Cambridge, UK.\', \'Milner Therapeutics Institute, University of Cambridge, Cambridge, UK; Department of Chemical Engineering and Biotechnology, University of Cambridge, Cambridge, UK.\', \'Milner Therapeutics Institute, University of Cambridge, Cambridge, UK; Centre for Therapeutics Discovery, LifeArc, Stevenage, UK.\', \'Milner Therapeutics Institute, University of Cambridge, Cambridge, UK. Electronic address: n.han@milner.cam.ac.uk.\']
?:citedBy
  • -1
?:creator
?:doi
  • S0169-409X(21)00038-710.1016/j.addr.2021.02.004
?:doi
?:hasPublicationType
?:journal
  • Advanced drug delivery reviews
is ?:pmid of
?:pmid
?:pmid
  • 33561453
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 4.09
?:rankingScore_hIndex
  • 261
?:title
  • Current and prospective computational approaches and challenges for developing COVID-19 vaccines.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33561453>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33561453>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all